100 related articles for article (PubMed ID: 8324843)
1. [Inhibitory effect of antitumor-B and retinamide on precancerous lesions of the bladder in rats].
Fan X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):71-3. PubMed ID: 8324843
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of urinary bladder cancer by N-(ethyl)-all-trans-retinamide and N-(2-hydroxyethyl)-all-trans-retinamide in rats and mice.
Thompson HJ; Becci PJ; Grubbs CJ; Shealy YF; Stanek EJ; Brown CC; Sporn MB; Moon RC
Cancer Res; 1981 Mar; 41(3):933-6. PubMed ID: 7459880
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of an aromatic retinoic acid analog on urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Murasaki G; Miyata Y; Babaya K; Arai M; Fukushima S; Ito N
Gan; 1980 Jun; 71(3):333-40. PubMed ID: 7418979
[TBL] [Abstract][Full Text] [Related]
4. [Medicamentous inhibitory therapy of precancerous lesions of the esophagus--3 and 5 year inhibitory effect of antitumor B, retinamide and riboflavin].
Lin P
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Aug; 12(4):235-45. PubMed ID: 2147582
[TBL] [Abstract][Full Text] [Related]
5. [Inhibitory effect of Chinese herb medicine zhuling on urinary bladder cancer. An experimental and clinical study].
Yang DA
Zhonghua Wai Ke Za Zhi; 1991 Jun; 29(6):393-5, 399. PubMed ID: 1935440
[TBL] [Abstract][Full Text] [Related]
6. Effect of vitamin A acetate on urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.
Miyata Y; Tsuda H; Matayoshi-Miyasato K; Fukushima S; Murasaki G; Ogiso T; Ito N
Gan; 1978 Dec; 69(6):845-8. PubMed ID: 750276
[TBL] [Abstract][Full Text] [Related]
7. The diverse modification of N-butyl-N-(4-hydroxybutyl) nitrosamine induced carcinogenesis in urinary bladder by dibromodulcitol and dianhydrodulcitol.
Szende B; Jeney A; Institoris L
Acta Morphol Hung; 1992; 40(1-4):187-93. PubMed ID: 1365762
[TBL] [Abstract][Full Text] [Related]
8. 13-cis-Retinoic acid: inhibition of bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Grubbs CJ; Moon RC; Squire RA; Farrow GM; Stinson SF; Goodman DG; Brown CC; Sporn MB
Science; 1977 Nov; 198(4318):743-4. PubMed ID: 910158
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Kitahori Y; Konishi N; Shimoyama T; Hiasa Y
Jpn J Cancer Res; 1985 Sep; 76(9):818-22. PubMed ID: 3932279
[TBL] [Abstract][Full Text] [Related]
10. Studies on medicamentous inhibitory therapy for esophageal precancerous lesions--3- and 5-year inhibitory effects of antitumor-B, retinamide and riboflavin.
Lin P; Zhang J; Rong Z; Han R; Xu S; Gao R; Ding Z; Wang J; Feng H; Cao S
Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(3):121-9. PubMed ID: 2098764
[TBL] [Abstract][Full Text] [Related]
11. A quantitative dosing schedule for the induction of transitional cell carcinomas in female F344 rats with the use of N-butyl-N-(4-hydroxybutyl)nitrosamine.
Becci PJ; Thompson HJ; Grubbs CJ; Moon RC
J Natl Cancer Inst; 1979 Jan; 62(1):187-91. PubMed ID: 281573
[No Abstract] [Full Text] [Related]
12. Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide,N-2-fluorenylacetamide, and 3,3'-dichlorobenzidine.
Tsuda H; Miyata Y; Murasaki G; Kinoshita H; Fukushima S
Gan; 1977 Apr; 68(2):183-92. PubMed ID: 892292
[No Abstract] [Full Text] [Related]
13. Effects of intravesical instillation of antitumor drugs on the induction of preneoplastic bladder lesions in rats.
Ohtani M; Fukushima S; Ito N; Koiso K; Niijima T
Cancer Chemother Pharmacol; 1983; 11 Suppl():S64-6. PubMed ID: 6416700
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
Becci PJ; Thompson HJ; Grubbs CJ; Squire RA; Brown CC; Sporn MB; Moon RC
Cancer Res; 1978 Dec; 38(12):4463-6. PubMed ID: 719631
[TBL] [Abstract][Full Text] [Related]
15. [Animal models of bladder cancer].
Fukushima S
Hinyokika Kiyo; 1988 Nov; 34(11):1923-7. PubMed ID: 3242366
[TBL] [Abstract][Full Text] [Related]
16. Strong promoting activity of reversible uracil-induced urolithiasis on urinary bladder carcinogenesis in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Shirai T; Tagawa Y; Fukushima S; Imaida K; Ito N
Cancer Res; 1987 Dec; 47(24 Pt 1):6726-30. PubMed ID: 3677102
[TBL] [Abstract][Full Text] [Related]
17. Paeonia lactiflora Pall inhibits bladder cancer growth involving phosphorylation of Chk2 in vitro and in vivo.
Ou TT; Wu CH; Hsu JD; Chyau CC; Lee HJ; Wang CJ
J Ethnopharmacol; 2011 Apr; 135(1):162-72. PubMed ID: 21396995
[TBL] [Abstract][Full Text] [Related]
18. [Secondary prevention of esophageal cancer--intervention on precancerous lesions of the esophagus].
Lin PZ; Zhang JS; Cao SG; Rong ZP; Gao RQ; Han R; Shu SP
Zhonghua Zhong Liu Za Zhi; 1988 May; 10(3):161-6. PubMed ID: 3219974
[TBL] [Abstract][Full Text] [Related]
19. [Effect of BBN on the small intestine transplanted to the urinary bladder of rat].
Wu B; Watanabe H; Nakagawa S; Sugimoto K
Hinyokika Kiyo; 1995 Sep; 41(9):665-8. PubMed ID: 7484529
[TBL] [Abstract][Full Text] [Related]
20. Lack of preventive efficacy of FK228, a histone deacetylase inhibitor, against N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder carcinogenesis in p53+/- and p53+/+ mice.
Wei M; Wanibuchi H; Morimura K; Salim EI; Moku M; Doi K; Mitsuhashi M; Masuda C; Shen J; Kinoshita A; Fukushima S
Anticancer Res; 2004; 24(2B):785-90. PubMed ID: 15161027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
